최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Molecular carcinogenesis, v.47 no.10, 2008년, pp.797 - 805
Zykova, Tatyana A. (Hormel Institute, University of Minnesota, Austin, Minnesota) , Zhu, Feng (Hormel Institute, University of Minnesota, Austin, Minnesota) , Zhai, Xiuhong (Hormel Institute, University of Minnesota, Austin, Minnesota) , Ma, Wei-Ya (Hormel Institute, University of Minnesota, Austin, Minnesota) , Ermakova, Svetlana P. (Hormel Institute, University of Minnesota, Austin, Minnesota) , Lee, Ki Won (Hormel Institute, University of Minnesota, Austin, Minnesota) , Bode, Ann M. (Hormel Institute, University of Minnesota, Austin, Minnesota) , Dong, Zigang (Hormel Institute, University of Minnesota, Austin, Minnesota)
Targeted molecular cancer therapies can potentially deliver treatment directly to a specific protein or gene to optimize efficacy and reduce adverse side effects often associated with traditional chemotherapy. Key oncoprotein and oncogene targets are rapidly being identified based on their expressio...
Int J Oncol Aziz MH 17 23 2003 Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (review)
Savouret, J.F, Quesne, M. Resveratrol and cancer: a review. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie, vol.56, no.2, 84-87.
Oak, Min-Ho, El Bedoui, Jasser, Schini-Kerth, Valérie B.. Antiangiogenic properties of natural polyphenols from red wine and green tea. The Journal of nutritional biochemistry, vol.16, no.1, 1-8.
Bode, A.M., Dong, Z.. Targeting signal transduction pathways by chemopreventive agents. Mutation research. Fundamental and molecular mechanisms of mutagenesis, vol.555, no.1, 33-51.
Bianchini, F, Vainio, H. Wine and resveratrol: mechanisms of cancer prevention?. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), vol.12, no.5, 417-425.
Jang, Meishiang, Cai, Lining, Udeani, George O., Slowing, Karla V., Thomas, Cathy F., Beecher, Christopher W. W., Fong, Harry H. S., Farnsworth, Norman R., Kinghorn, A. Douglas, Mehta, Rajendra G., Moon, Richard C., Pezzuto, John M.. Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes. Science, vol.275, no.5297, 218-220.
BHAT, KRISHNA P.L., PEZZUTO, JOHN M.. Cancer Chemopreventive Activity of Resveratrol. Annals of the New York Academy of Sciences, vol.957, no.1, 210-229.
Gusman, Julie, Malonne, Hugues, Atassi, Ghanem. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis, vol.22, no.8, 1111-1117.
Cancer Res She QB 1604 61 2001 Resveratrol‐induced activation of p53 and apoptosis is mediated by extracellular‐signal‐regulated protein kinases and p38 kinase
She, Qing-Bai, Huang, Chuanshu, Zhang, Yiguo, Dong, Zigang. Involvement of c-jun NH2-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Molecular carcinogenesis, vol.33, no.4, 244-250.
She, Qing-Bai, Ma, Wei-Ya, Wang, Mingfu, Kaji, Akira, Ho, Chi-Tang, Dong, Zigang. Inhibition of cell transformation by resveratrol and its derivatives: differential effects and mechanisms involved. Oncogene, vol.22, no.14, 2143-2150.
Tegeder, Irmgard, Pfeilschifter, Josef, Geisslinger, Gerd. Cyclooxygenase‐independent actions of cyclooxygenase inhibitors. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.15, no.12, 2057-2072.
Gasparini, Giampietro, Longo, Raffaele, Sarmiento, Roberta, Morabito, Alessandro. Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?. The Lancet. Oncology, vol.4, no.10, 605-615.
Oncol Rep Harris RE 559 13 2005 Aspirin, ibuprofen, and other non‐steroidal anti‐inflammatory drugs in cancer prevention: A critical review of non‐selective COX‐2 blockade (review)
Cancer Res Sheng H 362 58 1998 Modulation of apoptosis and Bcl‐2 expression by prostaglandin E2 in human colon cancer cells
Subbaramaiah, Kotha, Chung, Wen Jing, Michaluart, Pedro, Telang, Nitin, Tanabe, Tadashi, Inoue, Hiroyasu, Jang, Meishiang, Pezzuto, John M., Dannenberg, Andrew J.. Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells. The Journal of biological chemistry, vol.273, no.34, 21875-21882.
Murias, Marek, Handler, Norbert, Erker, Thomas, Pleban, Karin, Ecker, Gerhard, Saiko, Philipp, Szekeres, Thomas, Jäger, Walter. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure–activity relationship. Bioorganic & medicinal chemistry, vol.12, no.21, 5571-5578.
Martı́n, Antonio Ramón, Villegas, Isabel, La Casa, Carmen, de la Lastra, Catalina Alarcón. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochemical pharmacology, vol.67, no.7, 1399-1410.
Kundu, Joydeb Kumar, Shin, Young Kee, Surh, Young-Joon. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets. Biochemical pharmacology, vol.72, no.11, 1506-1515.
Wang, M., Jin, Y., Ho, C.-T.. Evaluation of Resveratrol Derivatives as Potential Antioxidants and Identification of a Reaction Product of Resveratrol and 2,2-Diphenyl-1-picryhydrazyl Radical. Journal of agricultural and food chemistry, vol.47, no.10, 3974-3977.
Reese, Jeff, Paria, Bibhash C., Brown, Naoko, Zhao, Xuemei, Morrow, Jason D., Dey, Sudhansu K.. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proceedings of the National Academy of Sciences of the United States of America, vol.97, no.17, 9759-9764.
Srivastava, Rupa, Ratheesh, Aparna, Gude, Rajiv K., Rao, K.V.K., Panda, Dulal, Subrahmanyam, Gosukonda. Resveratrol inhibits type II phosphatidylinositol 4-kinase: A key component in pathways of phosphoinositide turn over. Biochemical pharmacology, vol.70, no.7, 1048-1055.
Santra, Manas K., Panda, Dulal. Detection of an Intermediate during Unfolding of Bacterial Cell Division Protein FtsZ. The Journal of biological chemistry, vol.278, no.24, 21336-21343.
Bradford, Marion M.. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry, vol.72, 248-254.
Tang, Heng-Yuan, Shih, Ai, Cao, H. James, Davis, Faith B., Davis, Paul J., Lin, Hung-Yun. Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Molecular cancer therapeutics, vol.5, no.8, 2034-2042.
Cancer Res Sano H 3785 55 1995 Expression of cyclooxygenase‐1 and ‐2 in human colorectal cancer
Ito, Tetsuro, Akao, Yukihiro, Tanaka, Toshiyuki, Iinuma, Munekazu, Nozawa, Yoshinori. Vaticanol C, a Novel Resveratrol Tetramer, Inhibits Cell Growth through Induction of Apoptosis in Colon Cancer Cell Lines. Biological & pharmaceutical bulletin, vol.25, no.1, 147-148.
Wolter, Freya, Clausnitzer, Antje, Akoglu, Bora, Stein, Jürgen. Piceatannol, a Natural Analog of Resveratrol, Inhibits Progression through the S Phase of the Cell Cycle in Colorectal Cancer Cell Lines. The Journal of nutrition, vol.132, no.2, 298-302.
Sengottuvelan, Murugan, Viswanathan, Periaswamy, Nalini, Namasivayam. Chemopreventive effect of trans-resveratrol - a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis, vol.27, no.5, 1038-1046.
Athar, M., Back, J.H., Tang, X., Kim, K.H., Kopelovich, L., Bickers, D.R., Kim, A.L.. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicology and applied pharmacology, vol.224, no.3, 274-283.
Brown, Joanne R., DuBois, Raymond N.. COX-2: A Molecular Target for Colorectal Cancer Prevention. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.23, no.12, 2840-2855.
Koki, Alane T., Masferrer, Jaime L.. Celecoxib: A Specific COX-2 Inhibitor with Anticancer Properties. Cancer control : journal of the Moffitt Cancer Center, vol.9, no.2, 28-35.
Oncology (Williston Park) Blanke CD 17 16 2002 Celecoxib with chemotherapy in colorectal cancer
Dannenberg, Andrew J, Altorki, Nasser K, Boyle, Jay O, Dang, Chau, Howe, Louise R, Weksler, Babette B, Subbaramaiah, Kotha. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. The Lancet. Oncology, vol.2, no.9, 544-551.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.